CHIEF DEV. OFFICERCIK 0001742771
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $294K 27.7K sh | Oct 6, 2026 traded Oct 6, 2026 | |
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY |
Open-market sale · 10b5-1 plan |
| SELL |
| $374K 25.1K sh |
| Jul 7, 2026 traded Jul 7, 2026 |
| 1 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $35K 2,547 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 5 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Grant or award | A | — 70.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 16 | Naylor StuartCHIEF DEV. OFFICER | Open-market sale · 10b5-1 plan | SELL | $259K 27.7K sh | Apr 7, 2026 traded Apr 7, 2026 |
| 9 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | M | — 37.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 13 | Naylor StuartCHIEF DEV. OFFICER | Option exercise | M | — 37.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 12 | Naylor StuartCHIEF DEV. OFFICER | Tax withholding | F | $136K 17.6K sh | Jan 8, 2026 traded Jan 7, 2026 |